Eton Pharmaceuticals, Inc. · NASDAQ:ETON
Opaleye Management Inc. sold 126,685 Eton Pharmaceuticals, Inc. shares (Form 4)
Traded Jul 2 to Jul 7, 2026 · Filed Jul 7, 2026
From Jul 2 to Jul 7, 2026, Opaleye Management Inc. (10% owner) sold 126,685 Eton Pharmaceuticals, Inc. shares at an average US$37.64 for US$4.77M, leaving 53,315 shares. Filed Jul 7, 2026 (Form 4).
- Sold
- 126,685 shares
- Price
- US$37.64 average (US$37.39 to US$38.37)
- Value
- US$4.77M
- Holding after
- 53,315 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 2, 2026 | Common Stock, par value $0.001 per share | Sale | 65,000 | US$37.39 | 2,710,000 | Indirect |
| Jul 2, 2026 | Common Stock, par value $0.001 per share | Sale | 25,000 | US$37.39 | 60,000 | Indirect |
| Jul 6, 2026 | Common Stock, par value $0.001 per share | Sale | 10,000 | US$38.00 | 2,700,000 | Indirect |
| Jul 7, 2026 | Common Stock, par value $0.001 per share | Sale | 20,000 | US$38.37 | 2,680,000 | Indirect |
| Jul 7, 2026 | Common Stock, par value $0.001 per share | Sale | 6,685 | US$38.37 | 53,315 | Indirect |
Source
Related
- Eton Pharmaceuticals, Inc.
- Opaleye Management Inc.
- Eton Pharmaceuticals, Inc. shareholders
- Form 4/A · Opaleye Management Inc. · Jul 17, 2026
- Form 4 · Krempa David · Oct 6, 2026
- Form 4/A · Maier Paul V · Aug 31, 2026
- Form 4 · Krempa David · Aug 24, 2026
- Form 4 · Brynjelsen Sean · Aug 20, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026